ACW 7.69% 2.8¢ actinogen medical limited

Ann: Phase II Alzheimer's Disease Trial - results, page-80

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,290 Posts.
    lightbulb Created with Sketch. 244
    That's correct.
    The original trial was put to the FDA @ 35mg twice per day for 12 weeks.
    In the interests of the trial proceeding Bill took a punt that even at 10mg he would get a result and agreed to modify the dosage.

    That's why the XanaHES trial states the following:
    "Assess safety and tolerability of higher doses, with an exploratory efficacy assessment included"


 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.